Brit. med. J., 1966, 2, 860-862 The clinical management of tetanus poses a difficult therapeutic problem to physicians everywhere. Mortality from the disease remains high even in those medical centres endowed with the best facilities currently available. In many developing countries where the disease is prevalent, and medical services are inadequate for local needs, mortality figures are alarmingly high, especially among cases of neonatal tetanus (Tompkins, 1958; Loh Siew Gek, 1951) . In these circumstances any innovation in treatment that offers some hope of reducing mortality from the disease is worthy of trial, especially if it is simple, relatively inexpensive, and safe.
Diazepam (Valium) has two distinct pharmacological properties-tranquillizing and muscle-relaxant. In experimental work the drug has been shown to block spinal reflexes in anaesthetized cats (Randall et al., 1961) , and it has been used with benefit in the management of the " stiff-man syndrome," which previously was unamenable to any form of treatment (Howard, 1963) . These facts suggested that diazepam might be of value in the management of tetanus, and in October 1964 a therapeutic trial was started. Preliminary findings were encouraging (Hendrickse and Sherman, 1965) . The trial has since been completed, and this report summarizes our findings.
Material and Methods
When the trial started in October 1964 all new cases of tetanus seen in the Department of Paediatrics were randomly allocated into one of three treatment groups designated A, B, and C.
The following standard treatment was given to all groups: (1) paraldehyde by intramuscular injection for immediate control of spasms ; (2) anti-tetanus serum, 20,000 to 50,000 units, by intramuscular injection ; (3) penicillin, 150,000-300,000 units daily, for five days ; (4) as soon as initial sedation was secured with paraldehyde a gastric tube was passed through the nose, and subsequent medication was administered by this route during the early days of treatment ; and (5) additional antibiotics-for example, tetracycline-were used for complications such as bronchopneumonia.
The following regimens of sedation were then employed in the different groups:
Group A: Phenobarbitone, 4.4-6.6 mg./kg., and chlorpromazine 1.1-2.2 mg./kg. six-hourly. 
Neonatal Tetanus
There were 53 cases in group A, of which 14 were graded mild to moderate and 39 severe ( Table I ). The number of deaths in each grade was 2 and 27 respectively. The corresponding figures for group B were total cases 51, mildmoderate 18 with 4 deaths, severe 33 with 24 deaths. The overall mortality in groups A and B was identical (55%). 
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A number of the deaths in both groups were not directly related to tetanus, and in many instances death occurred at a time when the patients were obviously recovering from tetanus. Table II shows mortality directly attributable to tetanus, and  Table III gives details of these deaths excluded from Table II . The " corrected " mortality was 41 % in both groups. Tompkins, 1958 ).
The differences in mortality between groups A and B indicate that on the whole children in group B fared better than those in group A. The difference in the overall mortality in the two groups is, however, not statistically significant. The difference in the " corrected " mortality between the groups, though more marked, is also not statistically significant.
'Yates correction applied. The oral rout of administration was used almost exclusively in this trial and appeared to be perfectly satisfactory. Our limited experience of the intramuscular route of administration does not suggest that this has any special advantage over oral administration.
The intravenous route of administration was tried on a few occasions and did not appear to produce a dramatic onset of action of the drug.
No toxic effects attributable to diazepam were observed in either neonates or older children. The lower temperatures revealed among neonates who received diazepam, however, suggest that it tends to induce hypothermia. Mortality was not adversely affected by this action of the drug.
Summary and Conclusions
Results of therapeutic trial of diazepam in tetanus are reported. The trial included 149 patients-104 neonates and 45 older children. Patients were randomly allocated into two treatment groups, one of which received diazepam in addition to the standard treatment used in both groups.
In neonatal tetanus the mortality rate was unaffected by the use of diazepam, but the drug was of value in relieving tonic muscle spasm, in particular trismus.
A significant number of patients who received diazepam had minimum temperatures of 95°F. (350 C.) and lower, but did not appear to be adversely affected by this.
In older children with tetanus the overall mortality rate was lower among those who received diazepam than among those who did not, but the difference is not statistically significant. As in neonates, the drug was of value in relieving tonic spasm but did not seem to have any direct effect on convulsive spasms.
Findings in this trial indicate that diazepam is a useful drug in the management of tetanus, principally because of its ability to reduce tonic muscle spasm. Its use appears to be free of toxic effects or unpleasant side-actions. In older children it may have favourably influenced mortality from the disease.
The mortality from tetanus is still high in many parts of the world (Jelliffe, 1950 ; Johnstone, 1958 ; Tompkins, 1958 Tompkins, , 1959 Adams et al., 1959 ; Smythe, 1963 ; Kloetzel, 1963 Hendrickse and Sherman (1965) , in a preliminary report of a therapeutic trial of diazepam and chlorpromazine in neonates and children, found diazepam to be useful in tetanus, but could not draw definite conclusions because of the small number in their series.
Prior to its use in tetanus, diazepam had been found useful in treating skeletal-muscle spasms associated with conditions such as overriding fractures of the femur and tibia (Kestler, 1963) ; stiff-man syndrome (Howard, 1963) ; cervical and lumbar disc protrusion (Bain, 1964) ; and in the relief of spasticity in patients with upper-motor-neurone lesions (Leavitt et al., 1963) .
Diazepam is a tranquillizer and muscle-relaxant of the 1,4-benzodiazepine group. We have used this drug in the treatment of tetanus at the Lagos University Teaching Hospital with a view to assessing its value and shortcomings in the management of the disease. This paper describes our present experience.
Materials and Methods
Forty-two patients (19 males and 23 females) with tetanus were studied. Their ages ranged from 4 days to 50 years. Twenty-nine received diazepam from the time of admission,
